Chad W. Euler

4.0k citations
35 papers · 3.1k · 1 hit paper · h-index 24

Impact in

Papers in

    • Bacteriophages and microbial interactions 14
    • Antimicrobial Peptides and Activities 7
    • Microbial infections and disease research 5

Chad W. Euler

34 papers receiving 3.0k citations

Chad W. Euler's Hit Papers

Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials 2014 · 747 citations
7470+4+8Years since publication200400600

Peers

Chad W. Euler
Comparison fields: 5 of 98
  • Microbiology 558
  • Molecular Medicine 363
  • Ecology 1.4k
  • Endocrinology 223
  • Business and International Management 70
Replace Udi Qimron with:
Udi Qimron Israel
Laurent Debarbieux France
Eric Morello France
Daria Bottai Italy
J van Embden Netherlands
Mzia Kutateladze United States
Anthony W. Maresso United States
Cindy Fèvre France
Gilbert Verbeken Belgium
Bret R. Sellman United States
Chad W. Euler relative to Udi Qimron Israel Udi Qimron's profile →
Citations per field
00.5×1.5×2.3×
Udi Qimron · 1×
Citations per year

Countries citing papers authored by Chad W. Euler

Since Specialization
Citations

This map shows the geographic impact of Chad W. Euler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chad W. Euler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chad W. Euler more than expected).

Fields of papers citing papers by Chad W. Euler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chad W. Euler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chad W. Euler. The network helps show where Chad W. Euler may publish in the future.

Co-authors

The 25 scholars most cited alongside Chad W. Euler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chad W. Euler Line = papers co-authored together Chad W. Euler links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Hit paper breakdown →
2014747
2 2002441
3 2015217
4 2010198
5 2013183
6 2010152
7 2016116
8 2015103
9 202098
10 201990
11 201987
12 200582
13 202158
14 201856
15 201547
16 201445
17 200639
18 201339
19 201737
20 200535

About Chad W. Euler

Chad W. Euler is a scholar working on Ecology, Microbiology, Molecular Biology, Infectious Diseases and Public Health, Environmental and Occupational Health, having authored 35 papers that have together received 3.1k indexed citations. Recurring topics across this work include Bacteriophages and microbial interactions (14 papers), Antimicrobial Resistance in Staphylococcus (10 papers), Streptococcal Infections and Treatments (9 papers), Antimicrobial Peptides and Activities (7 papers), T-cell and B-cell Immunology (5 papers), Microbial infections and disease research (5 papers), Antibiotic Resistance in Bacteria (5 papers) and CRISPR and Genetic Engineering (5 papers). The work is most often cited by research in Microbiology (558 citations), Molecular Medicine (363 citations), Ecology (1.4k citations), Endocrinology (223 citations) and Business and International Management (70 citations). Chad W. Euler has collaborated with scholars based in United States, Spain and Portugal. Frequent co-authors include Vincent A. Fischetti, Mark J. Shlomchik, Jacqueline William, Sean R. Christensen, Luciano A. Marraffini, Xavier Duportet, Wenyan Jiang, Gregory W. Goldberg, David Bikard and Peter Chahales. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, PLoS ONE, The Journal of Immunology, Microbial Drug Resistance and PLoS Pathogens.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact